Guido Baechler, Founder of Mainz Biomed

Latest round: IPO. Guido Baechler is the CEO of Mainz Biomed, a molecular genetics diagnostic company specializing in the early detection of cancer.

About Guido Baechler

Guido Baechler is the CEO of Mainz Biomed, a molecular genetics diagnostic company specializing in the early detection of cancer. The company is preparing for U.S. FDA trials in 2025 for its mRNA-based next-generation colorectal cancer screening test, aiming for substantial growth in global markets and entry into the U.S. market.

Guido Baechler at a glance

More founders in Berkeley, CA, USA & Mainz, Germany (44)

Browse related founder lists (2)

Full founder directory · Investor directory · Company funding database · Fundraising library